VEGF-targetted intravitreal drug injections in the treatment of retinal diseases, where overexpression of VEGF leads to vascular leakage and neovascularization, constitute one of the most frequently practiced procedures in ophthalmology. This evidence concerns the gene VEGFA and Abnormal retinal morphology.